Sunesis Pharmaceuticals is a clinical stage biopharmaceutical company that is focused on the discovery, development and commercialization of small molecule therapeutics for oncology, inflammatory diseases and other unmet medical needs. The company is advancing its product candidates through in-house research and development efforts and strategic collaborations with leading pharmaceutical and biopharmaceutical companies. Sunesis Pharmaceuticals is publicly traded on NASDAQ under the ticker symbol SNSS. The company is located in South San Francisco, Calif., and employs approximately 115 people.
Partial Data by Infogroup (c) 2024. All rights reserved.